77 related articles for article (PubMed ID: 20413312)
1. Synthesis and opioid activity of novel 6-substituted-6-demethoxy-ethenomorphinans.
Czakó B; Marton J; Berényi S; Gach K; Fichna J; Storr M; Tóth G; Sipos A; Janecka A
Bioorg Med Chem; 2010 May; 18(10):3535-42. PubMed ID: 20413312
[TBL] [Abstract][Full Text] [Related]
2. (-)-N,N'-but-2-ene-1,4-diylbimorphinans.
Schmidhammer H; Smith CF; Dalkner E; Erlach D; Heuberger M; Rollinger JM
Pharmazie; 1991 Feb; 46(2):101-2. PubMed ID: 1649476
[TBL] [Abstract][Full Text] [Related]
3. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
[TBL] [Abstract][Full Text] [Related]
4. In vitro opioid receptor assays.
Taylor DA
Curr Protoc Pharmacol; 2011 Dec; Chapter 4():Unit 4.8.1-34. PubMed ID: 22147348
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
6. 3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
Bishop MJ; Garrido DM; Boswell GE; Collins MA; Harris PA; McNutt RW; O'Neill SJ; Wei K; Chang KJ
J Med Chem; 2003 Feb; 46(4):623-33. PubMed ID: 12570383
[TBL] [Abstract][Full Text] [Related]
7. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
8. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
9. An assessment of parameters in QuaSAR studies of narcotic analgesics and antagonists.
Katz R; Osborne S; Ionescu F; Andrulis P; Bates R; Beavers W; Chou PC; Loew G; Berkowitz D
NIDA Res Monogr; 1978; (22):441-63. PubMed ID: 30912
[No Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of 14-alkoxymorphinans. 22.(1) Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities.
Lattanzi R; Spetea M; Schüllner F; Rief SB; Krassnig R; Negri L; Schmidhammer H
J Med Chem; 2005 May; 48(9):3372-8. PubMed ID: 15857143
[TBL] [Abstract][Full Text] [Related]
11. Quantitative relationship between antinociceptive activity and opiate receptor affinity: the importance of lipophilicity.
Jacobson AE
NIDA Res Monogr; 1978; (22):129-45. PubMed ID: 30906
[No Abstract] [Full Text] [Related]
12. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
13. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
14. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
15. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Assessment of the agonist and antagonist activities of narcotic analgesic drugs by means of the mouse vas deferens.
Hughes J; Kosterlitz HW; Leslie FM
Br J Pharmacol; 1974 May; 51(1):139P-140P. PubMed ID: 4155332
[No Abstract] [Full Text] [Related]
17. Biphasic regulation of the acute μ-withdrawal and CCk-8 contracture responses by the ORL-1 system in guinea pig ileum.
Marini P; Romanelli L; Valeri D; Cascio MG; Tucci P; Valeri P; Palmery M
Pharmacol Res; 2012 Jan; 65(1):100-10. PubMed ID: 21875667
[TBL] [Abstract][Full Text] [Related]
18. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
[TBL] [Abstract][Full Text] [Related]
19. A new structural motif for mu-opioid antagonists.
Van den Eynde I; Laus G; Schiller PW; Kosson P; Chung NN; Lipkowski AW; Tourwé D
J Med Chem; 2005 May; 48(10):3644-8. PubMed ID: 15887972
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
